P
Patrick Ndase
Researcher at University of Washington
Publications - 27
Citations - 5635
Patrick Ndase is an academic researcher from University of Washington. The author has contributed to research in topics: Pre-exposure prophylaxis & Serodiscordant. The author has an hindex of 17, co-authored 27 publications receiving 5129 citations. Previous affiliations of Patrick Ndase include University of Maryland, Baltimore & Kenyatta National Hospital.
Papers
More filters
Journal ArticleDOI
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Jared M. Baeten,Deborah Donnell,Deborah Donnell,Patrick Ndase,Nelly Mugo,Nelly Mugo,James D. Campbell,Jonathan Wangisi,Jordan W. Tappero,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,Allan R. Ronald,Elioda Tumwesigye,Edwin Were,Kenneth H. Fife,James Kiarie,James Kiarie,Carey Farquhar,Grace John-Stewart,Aloysious Kakia,Josephine Odoyo,Akasiima Mucunguzi,Edith Nakku-Joloba,Rogers Twesigye,Kenneth Ngure,Cosmas Apaka,Harrison Tamooh,Fridah Gabona,Andrew Mujugira,Dana Panteleeff,Katherine K. Thomas,Lara Kidoguchi,Meighan Krows,Jennifer Revall,Susan Morrison,Harald S. Haugen,Mira Emmanuel-Ogier,Lisa Ondrejcek,Robert W. Coombs,Lisa M. Frenkel,Lisa M. Frenkel,Craig W. Hendrix,Namandjé N. Bumpus,David R. Bangsberg,Jessica E. Haberer,Wendy S. Stevens,Jairam R. Lingappa,Connie Celum +49 more
TL;DR: Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women, and both study medications significantly reduced the HIV- 1 incidence among both men andWomen.
Journal ArticleDOI
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
Jared M. Baeten,Thesla Palanee-Phillips,Elizabeth R. Brown,Elizabeth R. Brown,Katie Schwartz,Lydia Soto-Torres,Vaneshree Govender,Nyaradzo Mgodi,Flavia Matovu Kiweewa,Gonasagrie Nair,Felix Mhlanga,Samantha Siva,Linda-Gail Bekker,Nitesha Jeenarain,Zakir Gaffoor,Francis Martinson,Bonus Makanani,Arendevi Pather,Logashvari Naidoo,Marla Husnik,Marla Husnik,Barbra A. Richardson,Barbra A. Richardson,Urvi M. Parikh,John W. Mellors,Mark A. Marzinke,Craig W. Hendrix,Ariane van der Straten,Ariane van der Straten,Gita Ramjee,Zvavahera M. Chirenje,Clemensia Nakabiito,Taha E. Taha,Judith G. Jones,Ashley J Mayo,Rachel Scheckter,Jennifer Berthiaume,Edward Livant,Cindy Jacobson,Patrick Ndase,Rhonda White,Karen Patterson,Donna Germuga,Beth Galaska,Katherine E. Bunge,Devika Singh,Daniel W. Szydlo,Elizabeth T. Montgomery,Barbara S. Mensch,Kristine Torjesen,Cynthia I. Grossman,Nahida Chakhtoura,Annalene Nel,Zeda F. Rosenberg,Ian McGowan,Sharon L. Hillier +55 more
TL;DR: A monthly vaginal ring containing dapivirine reduced the risk of HIV-1 infection among African women, with increased efficacy in subgroups with evidence of increased adherence.
Journal ArticleDOI
Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
Ibou Thior,Shahin Lockman,Laura M. Smeaton,Roger L. Shapiro,Carolyn Wester,S. Jody Heymann,Peter B. Gilbert,Lisa Stevens,Trevor Peter,Soyeon Kim,Erik van Widenfelt,Claire Moffat,Patrick Ndase,Peter Arimi,Poloko Kebaabetswe,Patson Mazonde,Joseph Makhema,Kenneth McIntosh,Vladimir Novitsky,Tun-Hou Lee,Richard Marlink,Stephen W. Lagakos,Max Essex,Mashi Study Team +23 more
TL;DR: Breastfeeding with zidovudine prophylaxis was not as effective as formula feeding in preventing postnatal HIV transmission, but was associated with a lower mortality rate at 7 months, and both strategies had comparable HIV-free survival at 18 months.
Journal ArticleDOI
Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine
Shahin Lockman,Roger L. Shapiro,Laura M. Smeaton,Carolyn Wester,Ibou Thior,Lisa Stevens,Fatima Chand,Joseph Makhema,Claire Moffat,Aida Asmelash,Patrick Ndase,Peter Arimi,Erik van Widenfelt,Loeto Mazhani,Vladimir Novitsky,Stephen W. Lagakos,Max Essex +16 more
TL;DR: The response to nevirapine-based antiretroviral treatment among women and infants who had previously been randomly assigned to a single, peripartum dose of ne virapine or placebo in a trial in Botswana involving the prevention of the transmission of HIV-1 from mother to child was studied.
Journal ArticleDOI
HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention
Deborah Donnell,Jared M. Baeten,Namandjé N. Bumpus,Justin Brantley,David R. Bangsberg,Jessica E. Haberer,Andrew Mujugira,Nelly Mugo,Patrick Ndase,Craig W. Hendrix,Connie Celum +10 more
TL;DR: Plasma concentrations of tenofovir consistent with daily dosing were highly predictive of protection from HIV acquisition, and most of those who took PrEP seemed to have high and consistent adherence.